Oxcarbazepine structure
|
Common Name | Oxcarbazepine | ||
---|---|---|---|---|
CAS Number | 28721-07-5 | Molecular Weight | 252.268 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 457.2±55.0 °C at 760 mmHg | |
Molecular Formula | C15H12N2O2 | Melting Point | 215-216°C | |
MSDS | Chinese USA | Flash Point | 230.3±31.5 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of OxcarbazepineOxcarbazepine inhibits the binding of [3H]BTX to sodium channels with IC50 of 160 μM and also inhibits the influx of 22Na+ into rat brain synaptosomes with IC50 about 100 μM.Target: Sodium ChannelOxcarbazepine is an antiepileptic drug with a chemical structure similar to carbamazepine, but with different metabolism. Oxcarbazepine is rapidly reduced to 10,11-dihydro-10-hydroxy-carbazepine (monohydroxy derivative, MHD), the clinically relevant metabolite of oxcarbazepine. MHD has (S)-(+)- and the (R)-(-)-enantiomer [1]. Oxcarbazepine (oxcarb) 600 and 900 mg (2360 and 3540 mumol) was taken by 3 volunteers (2 female, 1 male; 45-67 kg; age 22-34 years) after an overnight fast. Blood, saliva and urine were collected for the next 72 h for assay of oxcarb, 10,11-dihydro-10-hydroxy-carbamazepine (OHcarb), and 10,11-dihydro-trans-10,11-dihydroxy-carbamazepine (diol). Oxcarb reached a maximum level of about 1 microgram/ml (3.93 mumol/l) within 1 h and dropped below the detection limit (0.1 microgram/ml = 0.39 mumol/l) within 3 h. The active metabolite OHcarb appeared in the blood before oxcarb and reached the higher maximum level of 7.4 microgram/ml (29 mumol/l) after 7 h [2]. Clinical indications: EpilepsyToxicity: Isolated cases of overdose with oxcarbazepine have been reported. The maximum dose taken was approximately 24,000 mg. All patients recovered with symptomatic treatment. |
Name | oxcarbazepine |
---|---|
Synonym | More Synonyms |
Description | Oxcarbazepine inhibits the binding of [3H]BTX to sodium channels with IC50 of 160 μM and also inhibits the influx of 22Na+ into rat brain synaptosomes with IC50 about 100 μM.Target: Sodium ChannelOxcarbazepine is an antiepileptic drug with a chemical structure similar to carbamazepine, but with different metabolism. Oxcarbazepine is rapidly reduced to 10,11-dihydro-10-hydroxy-carbazepine (monohydroxy derivative, MHD), the clinically relevant metabolite of oxcarbazepine. MHD has (S)-(+)- and the (R)-(-)-enantiomer [1]. Oxcarbazepine (oxcarb) 600 and 900 mg (2360 and 3540 mumol) was taken by 3 volunteers (2 female, 1 male; 45-67 kg; age 22-34 years) after an overnight fast. Blood, saliva and urine were collected for the next 72 h for assay of oxcarb, 10,11-dihydro-10-hydroxy-carbamazepine (OHcarb), and 10,11-dihydro-trans-10,11-dihydroxy-carbamazepine (diol). Oxcarb reached a maximum level of about 1 microgram/ml (3.93 mumol/l) within 1 h and dropped below the detection limit (0.1 microgram/ml = 0.39 mumol/l) within 3 h. The active metabolite OHcarb appeared in the blood before oxcarb and reached the higher maximum level of 7.4 microgram/ml (29 mumol/l) after 7 h [2]. Clinical indications: EpilepsyToxicity: Isolated cases of overdose with oxcarbazepine have been reported. The maximum dose taken was approximately 24,000 mg. All patients recovered with symptomatic treatment. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 457.2±55.0 °C at 760 mmHg |
Melting Point | 215-216°C |
Molecular Formula | C15H12N2O2 |
Molecular Weight | 252.268 |
Flash Point | 230.3±31.5 °C |
Exact Mass | 252.089874 |
PSA | 63.40000 |
LogP | 1.44 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.662 |
Storage condition | Store at RT |
Water Solubility | DMSO: ~9 mg/mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302 |
Precautionary Statements | P301 + P312 + P330 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
Hazard Codes | Xn,F |
Risk Phrases | 22-36-20/21/22-11 |
Safety Phrases | 16-36/37 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | HN8445000 |
HS Code | 2933990090 |
Precursor 10 | |
---|---|
DownStream 6 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Functionalized nanocarrier combined seizure-specific vector with P-glycoprotein modulation property for antiepileptic drug delivery.
Biomaterials 74 , 64-76, (2015) Despite optimal therapeutic regimen with currently available antiepileptic drugs (AEDs), approximately a third of epilepsy patients remain drug refractory. Region-specific overexpression of multidrug ... |
|
Development of a SPE-HPLC-MS/MS method for the determination of most prescribed pharmaceuticals and related metabolites in urban sewage samples.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 990 , 23-30, (2015) Based on regional prescription data several pharmaceuticals with variable amounts of prescription and corresponding metabolites were selected and analyzed in influent and effluent samples of the sewag... |
|
Enhanced brain delivery of lamotrigine with Pluronic(®) P123-based nanocarrier.
Int. J. Nanomedicine 9 , 3923-35, (2014) P-glycoprotein (P-gp) mediated drug efflux across the blood-brain barrier (BBB) is an important mechanism underlying poor brain penetration of certain antiepileptic drugs (AEDs). Nanomaterials, as dru... |
10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide,Oxacarbazepine |
10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide Oxacarbazepine |
Oxecarb |
OXCARBAMAZEPINE |
Trileptal |
Oxcarbapezine |
Ocarbazepine |
Oxetol |
Aurene |
Oxcarbazepine |
10-Oxo-10,11-dihydro-dibenzo[b,f]azepine-5-carboxylic acid amide |
10,11-Dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide |
10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide |
10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide |
5H-Dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro-10-oxo- |
EINECS 249-188-8 |
OXACARBAZEPINE |
MFCD00865307 |